Neutrophil transmigration across intestinal epithelia is thought to contribute to epithelial dysfunction and characterizes many inflammatory intestinal diseases. Neutrophils activated by factors, normally present in the lumen, release a neutrophilderived secretagogue activity to which intestinal epithelia respond with an electrogenic chloride secretion, the transport event which underlies secretory diarrhea. Using sequential ultrafiltration, column chromatographic, and mass and Raman spectroscopic techniques, neutrophil-derived secretagogue was identified as 5'-AMP. Additional studies suggested that neutrophil-derived 5'-AMP is subsequently converted to adenosine at the epithelial cell surface by ecto-5'-nucleotidase and that adenosine subsequently activates intestinal secretion through adenosine receptors on the apical membrane of target intestinal epithelial cells. These findings suggest that this ATP metabolite may serve as a neutrophil-derived paracrine mediator that contributes to secretory diarrhea in states of intestinal inflammation. (J. Clin. Invest. 1993.91:2320-2325
Introduction
Hydration of mucosal surfaces ofthe mammalian airway, pancreatic tree, and intestinal tract occurs by the transport event of electrogenic chloride secretion (1 ) . In the intestine, the anatomic subsite at which this secretory process occurs is the epithelial lining ofthe intestinal crypt (2) . The crypt is also the site where neutrophils migrate across the epithelium in acute inflammatory states and subsequently cluster in the crypt lumen to form the classic feature of intestinal inflammation, the crypt abscess (3) . Crypt abcesses may be modeled by layering isolated neutrophils onto monolayers of a human-derived cryptlike intestinal epithelial cell line, T84 (4) (5) (6) (7) . Exposure of the apical surface of T84 monolayers to neutrophils previously activated by agonists endogenous to the crypt lumen, such as Address correspondence to Dr. James L. Madara Receivedfor publication 8 December 1992. endotoxin and n-formulated peptides, elicits a short circuit current (I.C)' due to activation of electrogenic chloride secretion (5) (6) (7) . This chloride secretory process has the net effect of producing isotonic fluid secretion (1) and likely serves as a primitive defensive response by which mucosal surfaces are "flushed."
Stimulation of chloride secretion by neutrophils does not appear to require physical contact with the intestinal epithelium since buffer conditioned with activated neutrophils can elicit chloride secretion when applied to T84 monolayers (5) . This neutrophil-derived secretagogue (NDS) activity is effective predominately at the apical membrane, directly elicits chloride secretion from primary isolates of mammalian intestinal crypt epithelial cells (6) , and thus may contribute to the secretory diarrhea that occurs in states characterized by neutrophil migration across the crypt lumen. NDS activity can also be obtained from the human promyelocytic cell line HL-60 and the level of this activity is enhanced when these cells differentiate toward the neutrophil phenotype (7). Like neutrophilderived NDS, that obtained from HL-60 cells is water soluble and can pass through a 1 -kD nominal mol wt cutoff filter (7) . We now report the purification and identification of NDS. Although several compounds known to be produced by neutrophils can elicit chloride secretion when applied to the target epithelia in pure form at concentrations in the micromolar to millimolar range (8) (9) (10) , the NDS activity derived from neutrophils and HL-60 cells represents a metabolite not previously recognized as a paracrine mediator which may play a crucial role in neutrophil-intestinal epithelial crosstalk.
Methods
HL-60 cells were grown in RPMI medium with 10% (vol/vol) heat-inactivated fetal calf serum with 2 mM L-glutamine (Gibco Laboratories, Grand Island, NY) in 75-cm tissue culture flasks at 37°C and at 5% CO2. To prepare an enriched source of NDS, cells were washed in HBSS, pelleted at 100 g for 5 min and resuspended in distilled water at 108 cells/ml. Clarified lysate supernatant (12,000 g for 15 min) was passed through a 1,000 mol wt cutoff ultrafiltration membrane (Amicon) by 25 psi nitrogen gas.
Human peripheral blood neutrophils were isolated as previously described (5, 6, 1 1). A crude NDS-conditioned cell-free supernatant was obtained after neutrophil activation with 0.1 sg/ml phorbol myristate acetate (PMA), exactly as described before (6) . This supernatant was also size-filtered as outlined above for the HL-60-derived enriched NDS preparation.
Crude NDS so prepared from HL-60 cells or freshly isolated and activated human neutrophils was then fractionated by a technique we empirically identified as useful in isolating and purifying NDS bioactivity. Briefly, HPLC anion exchange chromatography was performed using a 30 mm X 2.1 mm DEAE 10-jm particle size column (Polypore; Brownlee Labs, Santa Clara, CA). Elution was with either a linear ammonium acetate gradient ( 100-200 mM in Fig. 1 ) or a linear (0-200 in Fig. 2 ) phosphate buffer (pH 7.0) gradient. After injection (0.25 ml) the column was washed for 5 min with either 100 mM ammonium acetate or 1 mM phosphate buffer, then the NDS was eluted over 5 min. Flow rate was 0.5 ml/min. In addition, a reverse phase (RP) HPLC method was used where indicated to quantitate adenosine. Briefly, the RP-HPLC system for adenosine, detected at 254 nm, used a 30 mm X 4.6 mm OD-300 column (Aquapore; Brownlee Labs). After sample injection, the column was washed with 97.5% 50 mM ammonium phosphate at pH 4.0 (solvent A) and 2.5% methanol (solvent B) at 0.25 ml/min for 6 min. Adenosine was eluted using a linear gradient of 80% solvent A/20% solvent B over 9 min at 0.5 ml/min. Using this system, 5'-AMP eluted in the void volume and was quantitated by incubating an aliquot of each NDS sample with 5'-nucleotidase (300 mg) for 30 min at 25°C before HPLC injection.
T84 cell monolayers were used as previously described (6, 7, 1 1 ) to assess NDS activity of the fractions generated by the above methods. T84 monolayers were plated on collagen-coated 0.33-cm2 nucleopore filters, interfaced with apical and basolateral Ag/AgCl and Calomel electrodes via agar bridges, and IS. was determined via the voltage clamp technique as previously described (6, 7, 1 1 ). Fractions obtained from column chromatography were individually lyophylized, reconstituted in HBSS, and the pH was adjusted if needed to 7.4. Each fraction was reconstituted to a volume equal to the original sample applied to the column and further dilutions made with the above buffer as specifically indicated.
Purified fractions obtained from the DEAE chromatography of the crude NDS were pooled and characterized by mass spectroscopy and other techniques as indicated below. Mass spectra were recorded on a PE-SCIEX API-III (Thornhill, Ontario) triple quadrupole mass spectrometer with a pneumatically assisted electrospray ionozation source. Samples were flow injected in 50% aqueous acetonitrile that contained 1% acetic acid for the positive ion mode. Collision of the protonated molecules with Ar gas at 60-eV energy produced fragment ions which were mass analyzed in the third quadrapole. Raman spectra of HPLCpurified NDS, at neutral pH, were kindly provided by Drs. Warner L. Peticolas and Gerald A. Thomas ofthe University of Oregon, and phosphorous content was determined by a colorimetric assay as previously described ( 12) .
Results
The HPLC assay shown in Fig. 1 yielded several absorbance peaks and NDS activity was contained in late fractions well removed from the fraction containing authentic adenosine. A tracing of column effluent absorbance at 254 nm is shown in Fig. 1 and the asterisk in this figure identifies the retention volume corresponding to authentic adenosine. To verify that the NDS activity so isolated from HL-60 cells corresponds to the NDS activity associated with supernates obtained from activated neutrophils, the fractionation patterns of NDS from these two sources were compared. DEAE HPLC elution profiles of the bioactive fraction were identical whether the source of NDS was from buffer conditioned with activated human peripheral blood neutrophils or from HL-60 lysates (Fig. 2) . Preincubation ofthe crude NDS preparation with either adenosine deamidase or 5'-adenylic acid deamidase ablated the activity while incubation with adenosine 5'-triphosphatase had no effect and S-adenosyl homocysteine hydrolase resulted in a 3 300 Figure 1 . cm-I suggesting the presence of an adenine-like molecule; (c) a parent compound of molecular mass 347 D (nominal mass) was found by electrospray ionization mass spectrometry ( 13 ) and protonated (m/z 348) and deprotonated (m/z 346) molecules were detected in positive and negative ion modes, respectively (Fig. 3) ; (d) collision-induced dissociation ofthe protonated molecule produced an abundant fragment with m/z 136, strongly suggesting the adenine base, and the parent molecule as well as all minor product ions were identical to those observed in the fragment ion spectrum of a 5'-adenosine monophosphate standard (Fig. 3) ; (e) phosphorous, determined by a colorimetric assay as previously described ( 12) , was found to be present in roughly equimolar quantities with adenine (de- termined from ultraviolet absorption). Together these results suggest the identity of NDS to be a monophosphate form of adenosine. To resolve which monophosphate form(s) ofadenosine represented NDS, fractionation patterns ofpurified monophosphates were examined. Injection of authentic adenosine 5 '-monophosphate (5 '-AMP), but not 3'-or 2'-AMP, onto the DEAE column resulted in an elution pattern identical to fractions demonstrating NDS activity (Fig. 2) . Lastly, incubation of either neutrophil or HL-60-derived NDS with 5'-nucleotidase, ablated the DEAE HPLC absorbance peak in which the native bioactivity resided (Fig. 2, open symbols) . Given the above findings, 5'-AMP was used as a tentative identification of NDS. We next tested a series of molecules chemically similar to 5'-AMP for NDS activity ( Table I) . As shown, an intact adenosine moiety appeared to be required for full activity. Deoxy analogues of the reagents shown in Table I failed to have any activity as did uridine analogues or guanine (data not shown). Addition of 5'-nucleotidase to either neutrophil or HL-60-derived NDS preparations ablated the HPLC peak in which the original bioactivity resided (Fig. 2) . 5'-AMP showed activity in the T84 bioassay similar to that of NDS purified by the above procedure. Time course, dose response, and sideness studies revealed the striking similarity between 5'-AMP and purified NDS (Fig. 4) . Interestingly, I.C responses to purified NDS and 5'-AMP were inhibited by the adenosine receptor antagonist 8-phenyltheophyline as effectively as adenosine (Fig. 5) . These findings suggested the possibility ofepithelial cell surface conversion of 5'-AMP to a subsequent effector (adenosine). Extracellular catabolism of 5 '-AMP to adenosine Table I . Effect ofStructural Analogues to 5'-AMP in Ic Responses in T84 Monolayers (9) Isc, uA-cm 2 Analogue (x ± SEM; n = 4) is known to be carried out by an ectoenzyme, ecto-5'-nucleotidase ( 14, 15) . The inhibitor of 5 '-ecto-nucleotidase activity, a-,8-methylene-ADP, strongly inhibited the ISC response to 5'-AMP but not adenosine (Fig. 5) . It thus appears that the ability of 5'-AMP to elicit NDS activity at the epithelial surface of T84 cells occurs, at least in part, because of metabolic processing of 5'-AMP to adenosine which subsequently recognizes adenosine receptors. Interestingly, DEAE HPLC column fractions of HL-60 lysates or freshly isolated and activated neutrophil supernantants, collected at a retention time which correlated to authentic adenosine, showed no activity in the bioassay with T84 cell monolayers. Thus insufficient authentic adenosine was released by neutrophils to contribute to the secretory response under these conditions. The RP-HPLC method was used to examine the relative molar concentrations ofadenosine and 5 '-AMP in neutrophil supernatants. Control and spiking experiments with authentic adenosine and 5'-AMP suggested that the 5'-nucleotidase used in this assay (see Methods) led to essentially complete conversion of 5'-AMP to adenosine, thus allowing for quantitation of components present in NDS preparations. Using this RP-HPLC assay it was found that, in supernatants from activated neutrophils, 5'-AMP was present in 10-100 X molar excess to authentic adenosine. DEAE experiments using spiking of NDS containing supernatants with 5'-AMP (such as shown in Fig. 2 ) revealed that 5'-AMP concentrations in primary neutrophil supernatants were -1 tIM and those in HL-60 lysates were 30-50 1AM. This correlated with dilutional bioassays which revealed -30 x greater NDS bioactivity in ultrafiltrates of HL-60 lysates as compared with ultrafiltrates of primary neutrophil supernatants (7) . (3, 5) , have free access to the apical membrane of crypt epithelial cells. We have previously reported that NDS is primarily effective when applied to this apical domain (5, 6) . Purification of NDS now shows it to be an effective secretagogue from both apical and basolateral domains although it is approximately an order of magnitude more effective apically. Since it appears from bioactivities and direct HPLC-based measurements that 5'-AMP is present in micromolar concentrations in neutrophil supernatants, since neutrophils induce an I. when added apically but not basolat-2324 Madara et al. 100 erally to T84 monolayers, and since micromolar 5'-AMP is sufficient to stimulate secretion apically but not basolaterally, it is likely that this agonist may be most effective when presented apically as in a crypt abscess. We also present evidence that neutrophil-derived 5'-AMP is converted at the apical membrane to adenosine. By its activity and sensitivity to a-0-methylene ADP, this apical 5'-AMPase activity appears to represent CD73, a cluster differentiation antigen now known to represent a glycosyl phosphatidylinositol-linked 5'-AMPase ectoenzyme (ecto-5'-nucleotidase) which has recently been cloned and sequenced ( 14) . Like many polarized mammalian cells, T84 cells target glycosyl phosphatidylinositol-linked membrane proteins, such as alkaline phosphatase, to the apical membrane (Kaoutzani, P., C. Parkos, and J. L. Madara, manuscript in preparation). Thus the distribution of this enzyme, along with functionally defined adenosine receptors, to the apical membrane would be expected. Recently defined monoclonal antibodies which immunostain ecto-5'-nucleotidase have been used to show dense immunoreactivity on the apical membranes of crypt (and surface) epithelial cells in the human intestine ( 15) . Thus the presence of this enzyme on the apical membrane of T84 cells recapitulates the natural condition found in crypt epithelia.
Based on the evidence presented here, the following hypothesis of NDS-elicited Cl-secretion, outlined in Fig. 6 , emerges: neutrophils in crypt abcesses release 5'-AMP which is Neutrophil migration induced by the prese of chemotactic agents in the crypt lumen converted to adenosine by the epithelial ecto-5'-nucleotidase residing on the apical membrane. Locally released adenosine could then serve as an effector for secretion by interacting with its receptor on this same domain. The resulting volume flush of the crypt lumen would serve to clear the crypt ofthe threat that initially stimulated neutrophil transepithelial migration. Thus 5'-AMP may function as a novel "paracrine" mediator that contributes to fluid secretion in active intestinal inflammation. If this hypothesis proves correct, better understanding of the regulation of the interactive components of this model could identify new strategies for the treatment of diarrhea associated with intestinal inflammation.
